/Investor DB

Anterra Capital — 2020 Investments

4 investments dated 2020 · listed companies and verified rows first · show all

Animolanimol-discovery.cominSeries A · Jan 2020 · $6M✓ verified

Animol is a biopharmaceutical company developing a proprietary pipeline of novel veterinary small-molecule drugs for both companion and farm animals, targeting areas from anti-parasitics to chronic diseases.

AgTechAI & Machine LearningBiotechDeep TechHealthtechBoston, US

Andrew Calabrese(Scientific Co-Founder)inAndrew Calabrese, Ph.D.(Scientific Co-Founder)Douglas E. Hutchens(CSO)inLogan Andrews(Head of Program Management)inPhilip Austin(Managing Partner, Anterra Capital; co-founder of Animol)inAndrew Plant(Executive Officer, Director)in

Co-investorsNovalis LifeSciencesDYDX Capital

Ampverseampverse.cominSeed · Sep 2020

Ampverse provides gaming marketing services—including influencer talent, esports, events, media and virtual worlds—connecting brands and game publishers with gaming audiences.

GamingMarketing TechMedia & Entertainment

Charlie Baillie(Chief Executive Officer)inTim Roemer(Chief Operating Officer)in

Co-investorsFirestartrGandel InvestVulpes Ventures

Enkoenko.agin𝕏Jun 2020 · $45M

Enko discovers and develops novel crop protection products for farmers using a proprietary AI and machine learning discovery platform to combat pests and diseases.

AgTechAI & Machine LearningBiotechBoston, US

Jacqueline Heard(Executive Officer, Director)inTom Meade(Chief Science Officer)Philip Austin(Director)inSteffen Helmling(Director)Anthony Klemm(CEO and Board Director)

Co-investorsAlumni VenturesCastor VenturesConnecticut InnovationsDYDX CapitalEndeavor8Germin8 Ventures+5 more

Invetxinvetx.comSeries A · Feb 2020 · $15M

Boston, US

Jurgen Horn(Executive Officer, Director)

BoardPhilip Austin(Director)in

Co-investorsF-Prime CapitalGV (Google Ventures)Casdin CapitalEight Roads VenturesNovo Holdings

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.